Influence of High Myopia on Outcomes of iStent Inject W Implantation Combined with Cataract Surgery up to 24 Months of Follow-Up. [PDF]
Background: The purpose of this study was to evaluate the 2-year postoperative outcomes of iStent inject W implantation combined with phacoemulsification, with a specific focus on comparing results between high myopia (HM) and non-high myopia (non-HM) eyes.
Shiotani Y +9 more
europepmc +3 more sources
Prevalence of zonulopathy in primary angle closure disease
Abstract Background To determine the prevalence of zonulopathy in a large cohort of eyes with primary angle closure disease (PACD) that underwent cataract surgery. Methods Retrospective consecutive case series of PACD eyes (including primary angle closure suspect, primary angle closure, and primary angle closure glaucoma) that underwent ...
Ali Salimi +5 more
wiley +1 more source
Abstract Purpose To evaluate the long‐term efficacy and safety of two minimally invasive glaucoma surgery implants with a subconjunctival drainage approach: the XEN45 Gel Stent® (Xen) implant and the PRESERFLO™ MicroShunt (MicroShunt). Methods Retrospective comparative case series of primary open‐angle glaucoma (POAG) patients with at least 6 months of
Lotte M.J. Scheres +7 more
wiley +1 more source
Introduction The purpose of this study was to compare the surgical outcomes between ab interno trabeculotomy (LOT) and iStent inject W implantation (iStent) both combined with cataract surgery, matching the background factors including age, intraocular ...
Ryo Asaoka +8 more
doaj +1 more source
Three-Year Outcomes of iStent Inject W Implantation Combined With Phacoemulsification in Japanese Eyes With Open-Angle Glaucoma: A Retrospective Study. [PDF]
Background Glaucoma is a leading cause of irreversible blindness. In Japan, most primary open-angle glaucoma (POAG) cases are normal-tension glaucoma (NTG). Micro-invasive glaucoma surgery (MIGS) such as the iStent inject W (Glaukos Corporation, San Clemente, CA) offers a less invasive option, but long-term outcomes in NTG-predominant populations are ...
Usami T +5 more
europepmc +4 more sources
Comparison Between Phacoemulsification-iStent Inject W and Phacoemulsification-Micropulse Transscleral Laser Therapy in Asian Eyes With Mild-Moderate Open Angle Glaucoma. [PDF]
Précis: In this retrospective cohort study, the 1-year cumulative probability of failure was comparable, achieving 52.20% in the phacoemulsification-iStent inject W (phaco/iStent) group and 47.80% in the phacoemulsification-micropulse transscleral laser therapy (phaco/MPTLT) group (P=0.994 ...
Figueras MM +9 more
europepmc +3 more sources
Translating Minimally Invasive Glaucoma Surgery Devices
Glaucoma is the leading cause of irreversible blindness with over 70 million people affected worldwide. The surgical management of glaucoma aims to lower intraocular pressure by increasing aqueous outflow facility. The latest manufacturing techniques have allowed for the development of a number of novel implantable devices to improve safety and ...
Richard M.H. Lee +4 more
wiley +1 more source
Postoperative Endophthalmitis after Combined Cataract Extraction and iStent Inject Implantation
Purpose. To report a case of postoperative endophthalmitis after combined cataract extraction and iStent inject implantation. Observation. A 70-year-old male with a nuclear sclerotic cataract and primary open-angle glaucoma underwent an uneventful ...
Mai Tsukikawa +3 more
core +1 more source
PERMANENT DATABASE - Learning Curve Phaco+iStent
Learning-Curved of Phaco+iStent inject assessed through 6 surgeons in a teaching hospital (residents and consultants)
Rafael Correia Barão (11097858) +2 more
core +1 more source
Refractive Outcomes After Trabecular Micro-Bypass Stents (iStent Inject) with Cataract Extraction in Open-Angle Glaucoma [PDF]
Purpose Simultaneous cataract and glaucoma surgery has traditionally been challenging for the anterior segment surgeon. The introduction of minimally invasive glaucoma surgery (MIGS) in conjunction with cataract surgery appears safe and effective in ...
Ioannidis, Alexandros S; https://orcid.org/ +3 more
core +1 more source

